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Abstract
Myocardial infarction is a derivative of heart disease that is a growing concern in the United
States today. With heart disease becoming increasingly predominant, it is important to not only
take steps toward preventing myocardial infarction, but also towards predicting future
myocardial infarctions. If we can predict that the dynamic pattern of an individual's diagnostic
history matches a pattern already identified as high-risk for myocardial infarction, more rigorous
preventative measures can be taken to alter that individual's trajectory of health so that it leads to
a better outcome. In this paper we utilize classification and clustering data mining methods
concurrently to determine whether a patient is at risk for a future myocardial infarction.
Specifically, we apply the algorithms to medical claims data from more than 47,000 members
over five years to: 1) find different groups of members that have interesting temporal diagnostic
patterns leading to myocardial infarction and 2) provide out-of-sample predictions of myocardial
infarction for these groups. Using clustering methods in conjunction with classification
algorithms yields improved predictions of myocardial infarction over using classification alone.
In addition to improved prediction accuracy, we found that the clustering methods also
effectively split the members into groups with different and meaningful temporal diagnostic
patterns leading up to myocardial infarction. The patterns found can be a useful profile reference
for identifying patients at high-risk for myocardial infarction in the future.
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Chapter 1
Introduction .
Myocardial infarction (also known as MI or a heart attack) is a derivative of heart disease that is
a growing concern in the United States today. The findings by the Centers for Disease Control
and Prevention claim that the leading cause of death in 2006 in the United States was heart
disease, with 631,636 deaths [1]. According to the Heart Disease and Stroke Statistics - 2010
Update from the American Heart Association, the estimated annual incidence of MI is 610,000
new attacks and 325,000 recurrent attacks [2]. This means that almost every 34 seconds an
American will suffer from a heart attack. With heart disease becoming increasingly
predominant, it is important to not only take steps towards preventing MI, but also towards
predicting future MI. If we can predict that the dynamic pattern of an individual's diagnostic
history matches a pattern already identified as high-risk for MI, more rigorous preventative
measures can be taken to alter that individual's trajectory of health so that it leads to a better
outcome.
MI is the death of the heart muscle due to the sudden blockage of a coronary artery by a blood
clot [3]. When the coronary artery is blocked, it deprives the heart muscle of blood and oxygen.
If the blood flow to the heart muscle is not restored in time, the heart muscle will begin to die.
The most common symptom of a heart attack is angina pectoris (also known as angina or chest
pain). Other common symptoms include shortness of breath, heartburn, arm pain, jaw pain,
toothache, headache, nausea and/or vomiting, and upper back pain. However, approximately 25
percent of all heart attacks are silent, meaning there are no symptoms [3]. Hyperlipidemia (high
blood cholesterol) is one of the main factors that increase the risk of developing atherosclerosis
and MI. Hypertension (high blood pressure), smoking, family history of heart disease, and
diabetes mellitus (both types 1 and 2) are also factors that increase the risk of MI. These
symptoms and risk factors will be used later to assemble the data in this study.
MI is an adverse event that is hard to predict, prevent, and even diagnose. Researchers are still
trying to determine the clinical characteristics of less typical presentations of patients in whom
MI was missed, even after admission to the emergency room [4]. The ambiguity behind some
MI events presents the need for understanding patterns in patient's diagnostic histories that are
linked to MI. One study attempts to attain this understanding using observational data from
ultrasound images of the common carotid artery [5]. The study found that increased common
carotid intima-media thickness is associated with future cardiovascular events such as
myocardial infarction. Although this procedural assessment is noninvasive and has shown to
successfully predict a heart attack, the underlying problem still remains: how to determine who
should have this procedure done. It is infeasible to perform this test on everyone and a threshold
is still needed to determine who is at risk. One way to find this is through the analysis of
temporal diagnostic data from administrative databases.
The amount of health insurance claims data collected, recorded, and filed into databases is vast.
Large databases containing medical information on millions of people are very scarce and
therefore insurance claims databases are more frequently being used to evaluate clinical
outcomes, adverse events, and future health care expenditures [6, 7, 8, 9]. A few of the many
advantages of insurance claims data include: the sample size of patients are very large and are
geographically diverse, the data contains multiple records on patients over extended periods of
time, the data is already collected and available at a low cost, the target population can easily be
defined, and there is an absence of reporting bias [10, 7]. However, many have questioned the
suitability of insurance claims information for use in medical research because the data is not
collected specifically for clinical care analysis but rather for financial reimbursement purposes.
There have been findings that suggest insurance claims data fail to identify prognostically
important conditions because the data lacks important details on diagnostic and prognostic
information that are commonly captured in the traditional clinical information system [10].
Insurance claims data do not report the outcomes from medical care received or changes in the
patient's functional status, sometimes making it difficult to use insurance claims data to
effectively measure the outcomes of care. Other studies claim that insurance claims contain
variability because of the lack of physician uniformity in naming patient conditions [11].
Nevertheless, many studies adequately combat these limitations and successfully show how
claims data can be used in medical research [7, 12, 9, 6].
One study by Wennberg el al. on the outcome of prostatectomy compensates for the lack of
information regarding outcomes of medical care by utilizing active participation of practicing
physicians to help improve the database [7]. The study combined the insurance claims from the
Medicare and the Manitoba Health Services Commission claims database with hospitalization
records and dates of death from the Medicare enrollment files or registry files. With this more
robust database, the incidence of mortality and nonfatal outcomes following prostatectomy
surgery were successfully measured. In another study done on the Veterans Health
Administration's discharge database, medical record abstraction data was compared to the
accuracy of the ICD-9-CM codes in the Patient Treatment File [12]. The study validated the use
of health insurance claims by finding that the probability a MI was present on admission given
that it was coded in the Patient Treatment File was high. Other examples include the use of ICD-
9-CM codes to detect adverse events such as adverse drug events, surgical adverse events,
misadventures, infections, device events, and other adverse events [9], and measuring outcomes
of medication adherence based on medical claims [6].
There are many different trajectories of health that can lead to a heart attack. In this paper we
utilize data mining methods to present and discuss ways to determine whether a patient is at risk
for a future heart attack based on the patient's past history of diagnoses. Specifically, we employ
clustering and classification algorithms concurrently on medical claims data from more than
47,000 members over five years to: 1) provide improved out-of-sample predictions of MI, 2) find
groups of members that have new and interesting temporal diagnostic patterns leading to MI and
3) show our method is a systematic way for finding patterns already known to lead to MI and can
be applied to other diseases and adverse events. We find that our methods effectively split the
members into groups with different clinical characteristics and uncover several interesting
dynamic diagnostic patterns. These diagnostic patterns provide meaningful insights into what
diagnosis combinations and profiles classify a patient as high-risk for MI and are strong
predictors of a future MI.
The rest of this paper is summarized as follows: In Section 2, we describe the data and the
criteria we use for its aggregation. In Section 3, we present both the supervised classification
algorithm and unsupervised clustering methods we use. In Section 4, we report the performance
of the MI predictions. In Section 5, we provide an in-depth discussion of the diagnostic patterns
uncovered. Finally, in Section 6 we briefly discuss our conclusions and provide suggestions for
future research.
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Chapter 2
The Data
When an individual receives care in a hospital or from a professional healthcare provider,
information about the service is recorded in order for the healthcare provider to receive
compensation. A medical coder is a medical records and health information technician that
specializes in translating and codifying the information regarding the patient's visit to the doctor
into a more universal medical record [13]. A set of published codes is used to assign a code to
each diagnosis, procedure, and prescription drug that is documented by the healthcare provider.
The universal codes then allow the insurance company to determine how much the health care
provider will be reimbursed. Therefore, a health insurance claim is a codified bill that the
healthcare provider sends to the insurance company to receive payment for their services.
There are two different types of health insurance claims: medical claims and pharmacy claims.
The main elements of a medical claim are the diagnosis and procedure codes while a pharmacy
claim contains prescription drug codes. There are different coding systems used for each of
these coded elements. Diagnostic codes group diseases, disorders, symptoms, and medical signs.
Procedure codes identify the specific health actions taken by professional health care providers.
The diagnosis and procedure data is coded using the ICD-9-CM (International Classification of
Diseases, Ninth Revision, Clinical Modification) codes [14]. ICD-9-CM is the universal coding
system created by the U.S National Center for Health Statistics (NCHS) for assigning codes to
diagnoses and procedures. Volumes 1 and 2 are used for diagnostic codes while Volume 3 is a
scheme of procedural codes. There are over 17,000 individual diagnostic ICD-9-CM codes and
over 25,000 individual procedure ICD-9-CM codes. We refer the reader to Appendix A for a
summary of the ICD-9-CM codes. Pharmacy claims are coded using prescription drug codes
from the National Drug Code (NDC) system [15]. NDC drug codes include some over-the-
counter drugs, insulin formulations, prescription drugs, and herbal drugs distributed in the United
States. There are over 317,000 individual NDC drug codes.
In addition to the medical, procedure, and drug codes, health insurance claims include other
important information pertaining to place of service, cost, and patient demographics. There are
approximately 100 different codes for specifying the location the care was received. A detailed
account of the dollar amount the insurance company reimbursed the health care provider for each
procedure performed and drug prescribed is documented. The date the diagnosis was given, the
procedure was performed, and/or the drug was prescribed is also documented. Finally,
information regarding the patient's gender, date of birth, and member identification number are
also documented in the health insurance claim.
2.1 Data Overview
The data used in this study is provided by Verisk Health, a company that leverages healthcare
data to identify, manage and minimize medical and financial risk at both the patient and
population levels. The data is generated from health insurance claims filed for 47,763 members
from a commercially insured population across the country over the observation period
01/27/2000 - 11/30/2007. The criteria for member selection for the study population are as
follows:
i. All members must have at least 5 Coronary Artery Disease (CAD) diagnosis codes and 5
hypertension diagnosis codes
ii. Data intake period for each member must be at least 5 years
a. Members should have at least 5 years of continuous eligibility
b. The most recent 5 years of data should be taken
iii. All members must have at least 100 medical claims
iv. All members must have at least 5 pharmacy claims
These criteria are used to ensure that all members of the study population have the same length
of eligibility within the same time period and have continuous coverage. The criteria also help to
define the target population and create a denser data set. With these criterion applied, the
resulting data set consists of 19,963,685 health insurance records. These health insurance
records include 13,217,714 individual medical records and 6,745,971 individual pharmaceutical
records for the 47,763 distinct members along with basic demographic information for each
member such as member identification number, date of birth, and gender.
2.2 Data Aggregation
As discussed earlier, there are over 17,000 diagnosis and 25,000 procedure ICD-9-CM codes and
317,000 drug NDC codes. If every diagnosis, procedure, and drug code were used, the data set
would have close to 360,000 attributes. In order to reduce the data set into a more workable size,
the diagnosis and procedure codes are broken down into groups of similar codes. The diagnosis
codes are reduced into 218 diagnosis groups, the procedure codes are reduced into 180 procedure
groups, and the prescription drug codes are reduced into 538 drug groups. The codes for each of
these groups were developed by Verisk Health. Refer to Appendix B for an example of how
diagnosis codes are reduced into a diagnosis group.
To further simplify the number of attributes, the data used in this study only includes 46 of the
218 diagnosis group codes and no procedure or drug group codes. The 46 diagnosis groups
chosen either directly correspond to a myocardial infarction event, can be causes of an MI, or are
risk factors for an MI. This simplification was done to eliminate diagnoses unrelated to a
Myocardial Infarction; for example, a broken leg. The remaining 172 diagnosis codes are
grouped into the variable: Other Diagnosis. See Appendix C for a detailed list of the diagnosis
groups used in this study.
Although there are only 47,763 members in the data set, there are over 13 million different
medical insurance records. This means that, on average, each patient has approximately 270
different diagnoses recorded over the observation period. To get a better view of each member's
past medical history, we want to compress the hundreds of medical records per member into one
record per member. This will provide us with a time-series record of the patient's diagnostic
profile over the observation period.
To achieve a time-series glimpse of each patient's medical history, the observation period is split
into 21 periods, each 90 days in length (see Appendix D). We look at the diagnoses given to the
patient during each 90 day period by counting the number of claims filed under each diagnosis.
For example, if a patient has 20 different claims filed for the diagnosis of chest pain in period 12,
the variable ChestPain Periodl2 would have a value of 20. This allows us to view the
diagnostic activity for each patient every 3 months. We also count the number of visits to the
hospital that the member has in each period. The other variables include the total medical cost
for each period and gender. Table 2.1 below shows a summary of the aggregated variables.
1 Member Identification Number
2 Gender
3 -49 Diagnosis group counts for period 1
50 Number of Emergency Room Visits for period 1
51 Total Medical Cost for period 1
52- 98 Diagnosis group counts for period 2
99 Number of Emergency Room Visits for period 2
100 Total Medical Cost for period 2
983 - 1029 Diagnosis group counts for period 21
1030 Number of Emergency Room Visits for period 21
1031 Total Medical Cost for period 21
Table 2. 1: Summary of Aggregated Variables
2.3 Shifting Time-Series Data
The target outcome we want to predict is the occurrence of a myocardial infarction diagnosis and
a trip to the emergency room. Our target variable consists of an MI diagnosis code and an ER
place of service code because the documentation of a MI diagnosis group code by itself does not
necessarily mean a heart attack occurred. The MI diagnosis group code not only accounts for MI
events but also for follow-up diagnoses such as post-myocardial infarction syndrome. Therefore,
considering an MI diagnosis along with a trip to the ER as our target variable will help to ensure
that the target outcome is in fact a heart attack. The target variable is binary: denoted {+ 1, -1 }
for the occurrence of an MI and ER event and no occurrence of an MI and ER event,
respectively. Since it is possible for patients in the dataset to have more than one episode of MI,
we only consider the first occurrence. We found that people experiencing multiple MI events
develop co-morbidities that bias their diagnostic history when compared those who have had no
previous MI.
For each member with MI and ER that is selected, we randomly select a member with no MI and
ER. Therefore, the dataset is balanced with an equal number of heart attack members and non-
heart attack members in the target variable. The non-MI member is chosen only if the member's
entire diagnostic history up to that point shows no MI event.
After the "yes MI" and "no MI" members are selected, we want to look at the 3 periods (9
months) of diagnostic history leading up to the MI/no-MI event for every member and compare
them. However, all of the MI/no-MI events occur across 21 different time periods. To compare
the diagnostic histories of all the patients concurrently, we align the data to make the
observations date-independent, thus preserving only the order of events. Figure 2.1 below
provides a visual timeline representation of the time-series data shift.
Period 3 Period 2 Period 1 Target
before Mi before MI before Mi Period
9 months
before MI
360
6 months
before MI
270
3 months
before MI
MI and ER
event
0180
Days
Figure 2.1: All MI events and no-MI events occur in a 90-day target period. The patient's
diagnostic history is recorded at 3 months (90-180 days), 6 months (180-270 days), and 9 months
(270-360 days) before the MI target period.
The time series shift has simplified the dataset even more, and we now only consider 48
variables per time interval. A summary of these variables is given in Table 2.2 below.
Variable
Number Description
1 Member Identification Number
2 Gender
3 - 49 Diagnosis group counts 9 months before M.I.
50 Total Cost 9 months before M.I.
51 - 97 Diagnosis group counts 6 months before M.I.
98 Total Cost 6 months before M.I.
99 - 145 Diagnosis group counts 3 months before M.I.
146 Total Cost 3 months before M.I.
147 MI and ER target outcome
Table 2.2: Summary of the variables used in this study
2.4 Cost Bucket Partitioning
The total cost of medical care in the three 90 day periods leading up to the MI and ER event
widely range from $0 to $636,508. Examining the cost structure of our data more closely, we
find that approximately 70% of the overall cost is generated by only 11% of the population. This
means that the high-risk patients with high medical expenses are a very small proportion of the
data and could skew our final results. According to the American Medical Association (AMA),
only 10% of individuals have projected medical expenses of approximately $10,000 or greater
per year, which is more than four times greater than the average projected medical expense of
$2,400 per year [16]. To lessen the effects of these high-cost outliers we divide the data into
three different cost buckets based on the findings by the AMA. Since cost is a good summary of
a person's health [29], cost bucket partitioning allows us to perform analysis on patients that
have similar conditions of health. Cost bucket 1 represents below average to average health-risk
members, cost bucket 2 represents average to above average health-risk members, and cost
bucket 3 represents high health-risk members. Table 2.3 below gives a summary of the cost
bucket partitions.
2 3
<$2,000-
$2,000 $10,000 $10,000
67.56% 21.56% 10.88%
S 4416 1409 711
36.14% 43.22% 38.12%
63.86% 56.78% 61.88%
Table 2.3: Cost bucket partition summary
Even though a higher percentage of the members fall into cost buckets 1 and 2, the data in these
cost buckets is sparse when compared to the data for members in cost bucket 3. This is because
members in the first two cost buckets have a less dense history of diagnoses.
2.5 Training and Test Set Selection
In order to effectively evaluate our model's ability to predict myocardial infarction, we ran out-
of-sample tests using independent test data. We randomly partition the full dataset into three
separate parts. The first part, the training set, is used to develop the model and fit it to the data.
The second part, the validation set, is used to adjust the model's parameters and assess the
performance of the prediction model. The last part, the test set, is used to evaluate how the
model performs on data that the chosen model has not previously seen - the generalization error
[17]. However, we do not have enough data in each cost bucket to set aside a validation set. To
handle this problem, we randomly split the data into only a training set and a test set. We use 10-
fold cross validation on the training set to obtain 10 different validation trials. The training set is
split into 10 equal parts so that for each trial, we use nine-tenths of the training set to train the
different models and the remaining one-tenth to calibrate the models and select the best
parameters. The model performance is then evaluated using the unseen test set. We ensure the
training set is balanced (contains an equal number of {+1, -1} values in the target variable) so
that neither class receives preferential treatment by the learning algorithm because of its
prevalence in the training set. The test set consists of the data left over and remains unbalanced
so that it represents the original distribution of the target variable values in the sample
population.
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Chapter 3
Methods
There are two different forms of statistical learning: supervised learning and unsupervised
learning. In supervised learning, we know the target outcome value and we build a model to
predict the known output using a set of input feature values. In unsupervised learning, we have
no measurement of the outcome variable. This form of learning uses the known feature values to
find patterns in the data or find relationships between the feature values. In this study, we will
use both forms of statistical learning concurrently. We will show that using supervised learning
alone yields weak results, but a joint approach increases the predictability of a heart attack. We
will first introduce the supervised and unsupervised learning methods we employ and then
discuss the steps and motivation behind our joint methodology.
3.1 Supervised Learning: Random Forest
3.1.1 Performance Metrics
To assess the performance of a supervised learning algorithm, many different performance
metrics are used. However, not all metrics are appropriate for every area of study because
different performance metrics measure different tradeoffs in the predictions made by a classifier
[18]. Additionally, supervised learning algorithms can yield strong performance with one metric
while performing weakly with others. We use the metric of accuracy which measures the total
number of correct predictions the model makes out of the entire tested population.
3.1.2 Random Forest Algorithm
The data in this study is labeled in advance and therefore using supervised learning to predict the
known class label (heart attack/ no heart attack) is appropriate. We choose the random forest
algorithm because of its attractive property of detecting variable interactions and excellent
performance as a learning algorithm. The algorithm estimates the importance of a variable by
looking at how much prediction error increases when data for that variable is permuted while all
others are left unchanged [19]. When tested on eight different performance metrics against nine
other supervised learning algorithms, random forests gave the second best average performance
across all of the metrics and different test problems [18].
The random forest algorithm builds a large collection of uncorrelated classification trees. A
classification tree is a decision tree that recursively partitions a dataset into smaller and smaller
groups that are similar based on the known class label. A single classification tree has a
hierarchical structure similar to the example in Figure 3.1 below. We can predict whether a new
member from the test set will have a heart attack by taking the member's information and
following the tree down its structure. In Figure 3.1, if the member has CAD and chest pain, we
predict a heart attack. However if the member has CAD but does not have chest pain, we predict
no heart attack. Similarly, if the member does not have CAD, we predict no heart attack.
Yes Chest No Chest No Heart
Pain Pain Attack
fYES Heart No Heart7Attack r Attack
Figure 3.1: Example of a classification tree structure
The many classification trees built by the random forest algorithm are much more complex with
many more diagnoses to consider. In the algorithm, a new member from the test set is classified
by taking the member's data and following each unique tree down its structure. Each tree will
output a classification for that member as "Yes Heart Attack" class or "No Heart Attack" class.
The random forest algorithm tallies the number of times the member was classified as either
"Yes" or "No" and then classifies the member by choosing the class that has the most votes out
of all of the trees in the forest. The parameter that requires tuning in this algorithm is t, the
number of trees to construct. The random forest model is built from the training data using 10-
fold cross-validation and different values of t to find the optimal value of t. The model with the
optimal value of t is then used on the unseen test set. For more details on the random forest
algorithm see [20].
3.2 Unsupervised Learning: Clustering Methods
Many times in data analysis we do not know the outcome variable corresponding to a given set
of input variables or features. Instead, we are either searching for relationships between the
input variables or trying to organize the data into different groups. In this study, we know the
outcome variable, heart attack or no heart attack, but we recognize that there are many different
trajectories of health that can lead to a heart attack. There is not one set pattern of health or
diagnostic combination that leads a person to a heart attack. Instead, we will show that there are
many different dynamic health patterns and time-series diagnostic relationships that can lead to a
heart attack. One way to segment the data and find these interesting groups with different health
patterns is through cluster analysis. Cluster analysis attempts to divide the data into different
groups, called clusters, so that the members of each cluster are more similar to each other than to
members of other clusters. There are several different clustering methods, but all of them are
fundamentally based on a measure of similarity between the individual members being clustered.
We consider two different clustering methods in this study: k-means clustering and spectral
clustering.
3.2.1 K-means Clustering
K-means clustering is based on the idea that data can be divided into clusters where each cluster
is represented by a center point [21]. This center point, also known as the centroid, is the mean
of the data within the cluster. To initiate the k-means algorithm, the number of clusters, k, must
be specified. The initial centroid locations for each of these k clusters can be specified or chosen
at random. Given an initial set of k centroids, the k-means algorithm assigns data points to the
initial clusters by minimizing the squared Euclidean distance from the data point to the centroid
of the cluster. Once all points are assigned to the closest centriod, the centroid (the mean) of
each cluster is recomputed. The points are then re-assigned to the closest centriod and the
centriods are recomputed again. These two steps occur repeatedly until the cluster assignments
do not change. In this study we use k = 5, 7, 10 and choose the initial centroid locations
randomly. More details on the algorithm can be found in [21].
3.2.2 Spectral Clustering
Many studies have shown that the spectral clustering algorithm is more effective in finding
clusters than traditional clustering algorithms such as k-means [22]. Spectral clustering
considers the pairwise similarity of data points while k-means only considers the similarity
values from the individual data points to their centroids. The algorithm is also attractive because
it is very simple to implement and can be solved efficiently by standard linear algebra methods
[23]. The algorithm is initiated by measuring the pairwise similarities of the data points and
constructing the corresponding similarity matrix. The number of clusters, k, must also be
specified. In this study we use k = 5, 7, 10. Details on the algorithm can be found in [22, 23].
We will use both k-means and spectral clustering methods to see how our results differ.
3.3 Baseline Performance
Mentioned briefly above, we utilize a joint methodology, with both supervised and unsupervised
learning, to predict a heart attack. In order to determine how well our joint method performs, we
devise a baseline method to compare our model's results to. Our baseline method uses only the
random forest supervised learning algorithm to predict a heart attack within each cost bucket. To
show that our joint methodology for heart attack prediction is meaningful, we will compare the
baseline performance to the performance of executing the random forest supervised learning
algorithm and unsupervised learning algorithms in parallel.
3.4 Joint Methodology
The most traditional use of supervised learning is in the context of binary classification. This
means that given all of the input features describing each member from the sample population, a
model is built to classify the members into two separate groups: one group with heart attacks and
one group without. However, categorizing the members in this way can be an oversimplification
of the problem because it assumes that members falling into the same class have similar health
characteristics. Therefore, we apply clustering algorithms to the data to first find different
groups of people with different health histories and then try to predict a MI event within each of
these sub-populations. Additionally, if interesting groups of people that are more at risk for a
heart attack do exist, the algorithms should find these groups. The diagnostic characteristics of
patients in these groups can help us to identify high-risk time-series health patterns that lead to
heart attacks.
Our method first takes the data from each cost bucket and divides it into training and test sets (as
explained in Section 2). The second step uses a clustering algorithm to cluster the training set,
with the target values omitted. This gives us a model with a set of k clusters. Each of the k
clusters is a different group of members that are described by different patterns of health. The
data from each of the k clusters is then used as training data to build k random forest
classification models. These models will be used to predict the occurrence of a heart attack
within each group of members. After the classification models are trained and validated using
10-fold cross validation, the left-over test set is then run through the cluster model already built
by the training data (target values omitted). The test set, previously unseen by the clustering
model, will now also be divided so that each member is assigned to a group that most closely
represents that member's diagnostic history. Now, each cluster consists of members from both
the training set and the test set. The test data from each of the k clusters is then used to test its
corresponding classification model. A visual representation of the method is shown if Figure 3.2
below.
Figure 3.2: Joint method using both supervised and unsupervised learning
The prediction performance of each classification model is then compared to the baseline
performance. An increased level of performance from the baseline means that clustering does
find interesting groups of people that have certain diagnostic characteristics over the time leading
up to a heart attack. Additionally, a strong prediction result for cluster k indicates that we can
successfully predict a heart attack for the types of members that fall in cluster k.
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Chapter 4
Prediction Results
4.1 Baseline Performance
We first ran the random forest classification algorithm using the randomly selected training set
from the data. The model's parameters were tuned using 10-fold cross validation. The model
chosen was then used to predict the class of the remaining withheld data in the testing set. We
then divided the data into cost buckets and applied the random forest algorithm again. Table 4.1
below shows the prediction results. All prediction results are color coded for viewing
convenience. A red tint indicates weak performance, a yellow tint mediocre performance, and a
green tint strong performance.
Table 4.1: Random forest classification results for each cost bucket.
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The first column in Table 4.1 above shows the overall prediction rate before cost bucketing. The
third column shows the prediction rates after the data was divided into cost buckets. The random
forest model poorly predicts MI in each of the cost buckets but shows a slight improvement from
the overall prediction rate. The last column of the table shows the prediction results after
clustering was applied to the cost buckets. These prediction results are from the spectral model
because it consistently outperformed the k-means model. The prediction rates improve after
applying clustering. More details on the clustering method results are discussed in the next
section.
4.2 Performance Using Clustering
In each cost bucket, the data is divided into a learning sample and a test sample. We first ran
both the spectral clustering and k-means clustering algorithms on the learning sample, leaving
out the target outcome variable (MI or no MI). The resulting clusters contain members with
similar cost and diagnostic characteristics. We then ran the random forest classification
algorithm on each cluster separately, using the data in each cluster for training and validation.
After the classification models for each cluster were chosen, we took the unseen test sample from
each cost bucket (without the target variable) and ran it through the previously developed cluster
models. This produced test samples for each cluster. Finally, we assign a prediction to each test
set using the previously developed classification models from each cluster. For a more detailed
description of this algorithm, refer to Section 3. We ran both the k-means and spectral clustering
algorithms for k = 5, 7, 10. The prediction performance of the random forest algorithm
monotonically increased with k, and therefore we only report the results for k = 10. Tables 4.2 -
4.5 below outline the cluster structures and prediction performance for each of the resulting
clusters by cost bucket. All prediction results are color coded for viewing convenience. A red
tint indicates weak performance, a yellow tint mediocre performance, and a green tint strong
performance. Rows highlighted in blue indicate clusters that have interesting temporal patterns,
relatively high prediction rates, and/or consist of a reasonably large number of members with MI
in the target period. Spectral clustering consistently performed better than k-means so we only
report the spectral clustering results. However, in cost bucket 2 we show the results from both
algorithms for comparison purposes later on.
4 86 75 161
5 52 57 109
6 300 245 545
7 77 136 213
Table 4.2: The resulting performance per cluster for spectral clustering in cost bucket 1.
Table 4.3: The resulting performance per cluster for spectral clustering in cost bucket 2.
...... .......... .
3 25 33 58
4 4 7 11
5 263 272 535
6 4 2 6
Tbelingherorceger cerortea67.17%
Table 4.4: The resulting performance per cluster for k-means clustering in cost bucket 2.
Table 4.5: The resulting performance per cluster for spectral clustering in cost bucket 3.
Tables 4.2 - 4.5 show that the weighted average prediction rate for each cost bucket is
considerably greater than the prediction rate found without clustering (Table 4.1) in both
clustering algorithms. This shows that clustering does improve our ability to predict MI.
Additionally, the weighted average prediction rate dramatically increases from cost bucket 1 to
cost bucket 3 with both clustering algorithms. This shows that overall, we predict MI better for
less healthy, more expensive patients. We also find that the spectral clustering algorithm has
higher overall weighted average prediction rates per cost bucket than the k-means clustering
algorithm.
Chapter 5
Patterns of Interest
The clusters resulting from both the spectral and k-means clustering models contain interesting
groups of members that have similar temporal diagnostic characteristics. As Tables 4.2 - 4.5
from Section 4 show, some clusters have a large disparity between the number of members who
experience MI in the target period and the number of members who do not. Additionally, some
clusters have high accuracy for MI prediction while other clusters do not. In order to find
interesting temporal patterns of diagnoses that can lead to a heart attack, we analyze the clusters
in more depth. The unique and interesting patterns were selected based on three criteria:
disparity between the number of members with MI and the number without, accuracy in the
prediction of MI, and an interesting diagnostic pattern not usually associated with MI.
In this section, we demonstrate that within each cost bucket there are several different temporal
patterns of diagnostic combinations that can lead people to a heart attack. We show that
although members from different clusters may have similar cost characteristics and high
probabilities of having a heart attack, the diagnostic trajectories of getting to the heart attack are
distinct. Many of the trajectories we found have been shown in independent studies to be
associated with or lead to MI. For cost bucket 2, we will discuss patterns for patients with
Chronic Obstructive Pulmonary Disease (COPD), a pattern for patients with a combination of
diagnoses leading to deteriorating health, patterns for patients with significant occurrence of
chest pain three months before the MI, patterns for patients with significant occurrence of
Coronary Artery Disease (CAD) three months before the MI, and patterns for patients
experiencing significant chest pain six months before the MI. For cost bucket 3, we will discuss
patterns for patients with anemia and patterns for patients with cerebrovascular disease. We will
also discuss patterns with diagnoses that are more commonly associated with MI; specifically
diabetes, hypertension, and hyperlipidemia diagnoses. These patterns appear consistently
throughout all of the cost buckets. Finally, we will discuss the clusters that have strong
prediction accuracy but consist of a larger number of members with no MI.
5.1 Pattern of gradually increasing occurrence of COPD
Cluster 7 from the spectral model in cost bucket 2, in Figure 5.1 below, displays a pattern where
patients regularly visit the doctor for COPD. Since the disparity between the number of
members who experience MI in the target period and the members who do not is moderate for
Cluster 7, (see Table 6 from Section 4) we look at the "yes MI" and "no MI" members
separately. However, we find that the diagnosis patterns of "yes MI" and "no MI" patients in
this cluster differ significantly. Therefore, to find the unique diagnostic characteristics that "yes
MI" members have in this cluster we only analyze at the "yes MI" pattern. In Figure 5.1 below,
the maroon line depicts the average number of doctor visits for each diagnosis for members with
MI in Cluster 7 while the blue columns are the average number of doctor visits for each
diagnosis for the entire population in cost bucket 2.
Bucket 2: Spectral Cluster 7
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Figure 5.1: Cluster 7 in the spectral clustering model from bucket 2.
The maroon colored line in Figure 5.1 above shows that members who experience MI in the
target period have an average of 4 visits to the doctor for COPD nine months before the MI, an
average of 7 visits for COPD six months before the MI, and an average of 9 visits three months
before. The average numbers of doctor visits for COPD are significantly larger than the average
number of visits for the overall bucket 2 population. This pattern also shows that members
experience Congestive Heart Failure (CHF) and anemia nine months before the MI and
pneumonia, CHF, and lower respiratory disorders both three and six months before the MI.
Table 5.1 below shows that compared to the cost bucket 2 population, the percentage of
members with COPD three, six, and nine months before the MI is much higher in Cluster 7. The
percentage with pneumonia and lower respiratory disorders is higher as well. Although
pneumonia is not usually associated with myocardial infarction, information from Massachusetts
.. . .. ..... . ....
General Hospital asserts that warning signs of a heart attack can often be confused with
indigestion, pneumonia, pleurisy, or other disorders [24].
Coronary Artery Disease
Chest Pain
9 months Congestive Heart Failure
Chronic Obstructive Pulmonary Disease
Hypertension
Anemias
Coronary Artery Disease
Chest Pain
Pneumonia
Diabetes
Congestive Heart Failure
Chronic Obstructive Pulmonary Disease
Hypertension
Lower Respiratory Disorders
Anemias
Shortness of Breath
Atrial Fibrillation
Coronary Artery Disease
Chest Pain
Pneumonia
Diabetes
Congestive Heart Failure
Chronic Obstructive Pulmonary Disease
Hypertension
Lower Respiratory Disorders
Anemias
Shortness of Breath
Atrial Fibrillation
6 months
i 29% 1
3 months
Table 5.1: Diagnoses that distinguish Cluster 7 from the cost bucket 2 population average. The
first two columns show the percentage of members who have the listed diagnosis.
Cost Bucket
2
23%
14%
6%
8%
26%
5%
23%
15%
4%
24%
7%
9%
27%
8%
6%
10%
5%
27%
18%
5%
26%
8%
10%
26%
9%
6%
11%
5%
25%
13%
22%
~41%
7% |
Cluster 8 from the k-means model also has a similar temporal pattern of COPD diagnoses as in
the spectral Cluster 7 above. In Figure 5.2 below we find that the most significant diagnosis
members in Cluster 8 experience nine, six, and three months before the MI is COPD. Table 5.2
shows that a very large percentage of members in this cluster have COPD nine, six, and three
months before the MI. In order to better show that this subgroup of members with COPD have
an increased risk of MI, we graph the Cluster 8 pattern against members from the bucket 2
population having a COPD diagnosis. Therefore, the blue columns in Figure 5.2 are the average
number of doctor visits for each diagnosis only for members in the cost bucket 2 population that
have at least one visit to the doctor for COPD. The significant difference in the average number
of doctor visits for COPD between Cluster 8 members and the conditional bucket 2 population
shows that members with this particular pattern and magnitude of COPD have an increased risk
of MI.
Figure 5.2 also shows that members in Cluster 8 visit the doctor an average of 10 times for CAD
nine months before the MI. This is different from what we found in Cluster 7 above, but Table
5.2 below shows that only 33% of members in this cluster actually visit the doctor for CAD.
Therefore, this small percentage of members is unrepresentative of the Cluster 8 population and
the result for CAD nine months before the MI is skewed. In addition to the COPD diagnosis,
members in this cluster develop CHF, respiratory failure, and lower respiratory disorders six and
three months before the MI and then peripheral vascular diseases and diseases of pulmonary
circulation three months before the MI. The patterns of COPD found in these clusters are
supported by an independent study done on the management of COPD patients. Researchers in
this study found that in patients with acute myocardial infarction, the incidence of COPD was
approximately 50% higher than in the general population [26].
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Cost Bucket Cluster 8 Diagnosis
2 _uster_8
23% 33% Coronary Artery Disease
24% 33% Diabetes
6% 14% Congestive Heart Failure
8% 9 months Chronic Obstructive Pulmonary Disease
5% 14% Anemias
8% Shortness of breath
16% 19% Hyperlipidemia
2% Asthma
23% Coronary Artery Disease
15% Chest Pain
4% Pneumonia
24% 38% Diabetes
7% Congestive Heart Failure
9% 6 months Chronic Obstructive Pulmonary Disease
27% Hypertension
8% Lower Respiratory Disorders
2% Respiratory Failure
6% Anemias
10% Shortness of breath
18% 24% Chest Pain
26% 24% Diabetes
8% Congestive Heart Failure
10% Chronic Obstructive Pulmonary Disease
26% 24% 3 months Hypertension
9% Lower Respiratory Disorders
5% Respiratory Failure
11% Shortness of breath
5% Peripheral Vascular Diseases
1% Diseases Pulmonary Circulation
Table 5.2: Diagnoses that distinguish Cluster 8 from the cost bucket 2 population average. The
first two columns show the percentage of members who have the listed diagnosis.
5.2 Pattern of Deteriorating Health
Cluster 1 from the k-means model in cost bucket 2 not only has a high prediction rate, but also
possesses a temporal pattern of an interesting combination of diagnoses that is much different
.......... -
than the general population of members in cost bucket 2. Figure 5.3 provides a graphical
representation of this pattern. The red line depicts the average number of doctor visits for each
diagnosis for members in Cluster 1. The blue columns are the average number of doctor visits
for each diagnosis for the entire population in cost bucket 2.
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Figure 5.3: Cluster 1 in the k-means clustering model from bucket 2.
The red line in Figure 5.3 shows the progressive deterioration of health for the members in
Cluster 1. Leading up to the heart attack in the target period, members in this cluster go to the
doctor an average of 2 times with CHF and anemia nine months before the MI. Six months out
from the MI, members visit the doctor an average of 2 times with pneumonia, CHF, and anemia.
Three months before the MI, the health condition of members becomes worse and it is the
combination of diagnoses that makes these members unique. Members visit the doctor an
average of 4 times with CAD, almost 5 times with pneumonia, anemia, and shortness of breath,
almost 6 times with CHF, almost 4 times with COPD, lower respiratory disorders, and
respiratory failure, and 2 times with a cough. Many of these diagnoses that the members
experience three months before the MI can be associated with a bad episode of the flu and
because of these misdiagnoses, some cardiologists believe that the signs and symptoms of a heart
attack are often missed [25]. They say that many times a patient's routine Electrocardiogram
(EKG) will show signs of a recent heart attack and the patient has no idea a heart attack
occurred. Instead, the patient thinks they have a really bad flu [25]. Table 5.3 below shows that
in particular, the percentages of members in Cluster 1 with pneumonia, lower respiratory
disorders, shortness of breath, and a cough three months before the MI are much greater than the
overall cost bucket 2 population percentages.
23% 19% Coronary Artery Disease
3% 11% Pneumonia
6% 9 months Congestive Heart Failure
8% Chronic Obstructive Pulmonary Disease
5% F 6% Anemias
3% MMyocardial Diseases
23% 28% Coronary Artery Disease
4% MPneumonia
7% 6 months Congestive Heart Failure
8% MLower Respiratory Disorders
6% | 11% Anemias
27% 39% Coronary Artery Disease
5% Pneumonia
26% 33% Diabetes
8% Congestive Heart Failure
9% Dysrhythmias
10% Chronic Obstructive Pulmonary Disease
26% 33% Hypertension
9% 3 months Lower Respiratory Disorders
5% Respiratory Failure
6% Anemias
11% Shortness of breath
5% Peripheral Vascular Diseases
5% Atrial Fibrillation
2% 8% Asthma
5% Myocardial Diseases
3% Cough
Table 5.3: Diagnoses that distinguish Cluster I from the cost bucket 2 population average. The
first two columns show the percentage of members who have the listed diagnosis.
5.3 Pattern of significant occurrence of Chest Pain 3 Months before MI
Cluster 1 from the spectral model in cost bucket 2, shown in Figure 5.4, depicts a pattern of
numerous doctors visits for chest pain three months before the MI. The red line depicts the
average number of doctor visits for each diagnosis for members in Cluster 1. The blue columns
are the average number of doctor visits for each diagnosis for the entire population in cost bucket
2.
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we would expect for a member that is about to experience MI, it is interesting and useful to find
this pattern in a systematic way.
FREQUENCY
Cost Bucket Cluster 1 Diagnosis
2
23% 14% Coronary Artery Disease
26% 24% 9 months Hypertension
8% 14% Lower Respiratory Disorders
23% 18% Coronary Artery Disease
15% 18% 6 months Chest Pain
27% 18% Hypertension
27% Coronary Artery Disease
18% 3 months Chest Pain9% Dysrhythmias
26% 27% Hypertension
Table 5.4: Diagnoses that distinguish Cluster 1 from the cost bucket 2 population average. The
first two columns show the percentage of members who have the listed diagnosis.
Cluster 7 in the k-means model, shown in Figure 5.5 below, also has a pattern of chest pain 3
months before the MI similar to spectral cluster 1 above. In order to better show that this
subgroup of members with chest pain have an increased risk of MI, we graph the Cluster 7
pattern against members from the bucket 2 population having a chest pain diagnosis three
months before the target MI period. Therefore, the blue columns in Figure 5.5 are the average
number of doctor visits for each diagnosis only for members in the cost bucket 2 population that
have at least one visit to the doctor for chest pain three months before the target period.
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Figure 5.5: Cluster 7 in the k-means clustering model from bucket 2.
The red line in Figure 5.5 above shows that members in Cluster 7 have a moderate history of
visits to the doctor six and nine months before the MI. The temporal pattern of this cluster only
differs from the cost bucket 2 averages in a few places: nine months before the MI, members
visit the doctor an average of 2 times for chest pain and about once for lower respiratory
disorders and six months before the MI, members visit the doctor an average of 2 times for chest
pain. Then, three months before the MI, members visit the doctor an average of 9 times for
i
CAD, almost 25 times for chest pain, and 2 times for hypertension. The significant difference in
the average number of doctor visits for chest pain three months before the MI between Cluster 7
members and the conditional bucket 2 population shows that members with this particular
pattern and magnitude of chest pain have an increased risk of MI.
Table 5.5 below shows that while a higher percentage of members in Cluster 7 have chest pain
six and nine months before the MI (when compared to cost bucket 2 percentages), three months
before the MI 100% of the members have chest pain. Additionally, the percentage of members
in Cluster 7 that have lower respiratory disorders nine and three months before the MI are higher
than the overall cost bucket 2 percentages.
FREQUENCY
Cost
Bucket 2 Clustei
14%
8% 13%
26% 19%
8%
23% 22%
11% 16%
15%
7% 6%
27% 22%
10% 19%
27%
18%
26% 25%
8% 6%
9%
26% 31%
9%
11% 19%
I Diagnosis
Chest Pain
9 months Chronic Obstructive Pulmonary Disease
Hypertension
Lower Respiratory Disorders
Coronary Artery Disease
Ear, Nose, Throat & Upper Respiratory Disorders
6 months Chest Pain
Congestive Heart Failure
Hypertension
Shortness of breath
Coronary Artery Disease
Chest Pain
Diabetes
3 months Congestive Heart Failure
Dysrhythmias
Hypertension
Lower Respiratory Disorders
Shortness of breath
Table 5.5: Diagnoses that distinguish Cluster 7 from the cost bucket 2 population average. The
first two columns show the percentage of members who have the listed diagnosis.
5.4 Pattern of significant occurrence of CAD 3 Months before MI
Cluster 6 from the spectral model in cost bucket 2, shown below in Figure 5.6, depicts a pattern
of numerous doctors visits for CAD three months before the MI. Since the disparity between the
number of members who experience MI in the target period and the members who do not is
moderate for Cluster 6, we look at the "yes MI" and "no MI" members separately. This helps to
determine what unique diagnostic characteristics the "yes MI" members have and why we
predict MI so well for this cluster. In Figure 5.6, the maroon line depicts the average number of
doctor visits for each diagnosis for members with MI in Cluster 6 and the green line depicts
average number of doctor visits for each diagnosis for members with no MI in Cluster 6. The
blue columns are the average number of doctor visits for each diagnosis for the entire population
in cost bucket 2.
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Figure 5.6: Cluster 6 in the spectral clustering model from bucket 2.
Members in Cluster 6 have a relatively low number of doctor visits until 3 months before the MI
target period. The maroon colored line in Figure 5.6 above shows that members who have MI in
the target period visit the doctor an average of 22 times with the CAD diagnosis. The line also
shows that members with MI in the target period have more visits to the doctor for chest pain,
Congestive Heart Failure (CHF), lower respiratory disorders, and shortness of breath. Table 5.6
below shows that compared to the entire cost bucket 2 population, the percentage of members in
Cluster 6 with these diagnoses three months before the MI is much higher.
FREQUENCY
Cost Bucket Cluster 6 Diagnosis
23% 28% Coronary Artery Disease
14% 7% 9 months Chest Pain
24% 14% Diabetes
26% 35% Hypertension
23% 25% Coronary Artery Disease
15% 7% 6 months Chest Pain
24% 19% Diabetes
27% 19% Hypertension
27% Coronary Artery Disease
18% Chest Pain
26% 21% Diabetes
8% 3 months Congestive Heart Failure
26% Hypertension
9% Lower Respiratory Disorders
11% Shortness of Breath
Table 5.6: Diagnoses that distinguish Cluster 6 from the cost bucket 2 population average. The
first two columns show the percentage of members who have the listed diagnosis.
5.5 Pattern of significant occurrence of Chest Pain 6 Months before MI
Cluster 8 from the spectral model in cost bucket 2, shown in Figure 5.7 below, consists of
members who visit the doctor numerous times for chest pain six months before the MI. The red
line depicts the average number of doctor visits for each diagnosis for members in Cluster 8.
The blue columns are the average number of doctor visits for each diagnosis for the entire
population in cost bucket 2.
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Figure 5.7: Cluster 8 in the spectral clustering model from bucket 2.
The red line in Figure 5.7 above shows that members from Cluster 8 visited the doctor an
average of 18 times for chest pain six months before the MI. Although chest pain is the key
warning sign of an immediate heart attack, the timing of this diagnosis is surprising. We also
fmd that members in Cluster 8 have a greater number of visits to the doctor for asthma than
normal. Table 5.7 below shows that 100% of the members in Cluster 8 visit the doctor for chest
pain 6 months before the MI and a high percentage of members have CAD, lower respiratory
disorders, and shortness of breath 6 months before the MI.
Cluster 8 Diagnosis
I 4 y
16%
13%
27%
18%
| 33% |
| 4%
23%
14%
26%
16%
23%
15%
27%
8%
10%
2%
27%
18%
26%
8%
26%
2%
9 months
Coronary Artery Disease
Chest Pain
Hypertension
Hyperlipidemia
Coronary Artery Disease
Chest Pain
6 months Hypertension
Lower Respiratory Disorders
Shortness of Breath
Asthma
3 months
Coronary Artery Disease
Chest Pain
Diabetes
Congestive Heart Failure
Hypertension
Asthma
Table 5.7: Diagnoses that distinguish cluster 8 from the cost bucket 2 population average. The
first two columns show the percentage of members who have the listed diagnosis.
5.6 Pattern of gradually increasing occurrence of Anemia
Figure 5.8 below is a graphical representation of the temporal diagnosis pattern of anemia in
Cluster 4 from cost bucket 3. In order to better show that this subgroup of members with anemia
have an increased risk of MI, we graph the Cluster 4 pattern against members from the bucket 2
population having an anemia diagnosis. Therefore, the blue columns in Figure 5.8 are the
average number of doctor visits for each diagnosis only for members in the cost bucket 2
population that have at least one visit to the doctor for anemia.
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9 visits to the doctor for anemia. This increases to an average of 11 visits six months before the
MI and then an average of 15 visits three months before the MI. Table 5.8 shows that a very
large percentage of members in this cluster have anemia nine, six, and three months before the
ML. In addition, the significant difference in the average number of doctor visits for anemia
between Cluster 4 members and the conditional bucket 2 population shows that members with
this particular pattern and magnitude of anemia have an increased risk of MI. According to the
International Academy of Cardiology, a study done at Brigham and Women's Hospital found
that "anemia has been shown to significantly decrease oxygen delivery to the myocardium and
increase the myocardial oxygen demand". The increase in blood viscosity can lead to a decrease
in coronary blood flow which can ultimately lead to thrombosis and MI. [27].
luster 4
25%
8%
46%
Diagnosis
9 months
Coronary Artery Disease
Chest Pain
Diabetes
Respiratory Failure
Anemias
Peripheral Vascular Diseases
Metabolic Disorders
Cost Bucket
3
26%
14%
31%
4%
8%
4%
3%
28%
21%
29%
1%
10%
3%
16%
6%
32%
19%
28%
11%
6%
Coronary Artery Disease
Chest Pain
Diabetes
Anemias
Metabolic Disorders
Table 5.8: Diagnoses that distinguish Cluster 4 from the cost bucket 3 population average. The
first two columns show the percentage of members who have the listed diagnosis.
5.7 Pattern of gradually increasing occurrence of Cerebrovascular Disease
Further analysis of Cluster 5 from cost bucket 3 shows that relative to the general population of
cost bucket 3, it has a unique and interesting temporal pattern of cerebrovascular disease that
leads to MI. Figure 5.9 provides a graphical representation of this pattern.
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Figure 5.9: Cluster 5 in the spectral clustering model from bucket 3.
From the red line in Figure 5.9 above we observe that members from Cluster 5 have a
reoccurring pattern of doctor visits that include diagnoses of hypertension and cerebrovascular
disease. To highlight the significant disparity between the average number of doctor visits for
cerebrovascular disease for members in Cluster 5 and the overall cost bucket 2 population, we
color the cerebrovascular disease diagnosis in green on the graph above. The pattern also shows
that members of this cluster have more health complications occurring six months before the MI.
Nine months before the MI, members only have visits to the doctor for ENT and upper
respiratory disorders, hypertension, and cerebrovascular disease. Six months from the MI,
members have a more complicated combination of diagnoses to include ENT and upper
respiratory disorders, chest pain, pneumonia, hypertension, and cerebrovascular disease. Three
months before the MI members have hypertension, cerebrovascular disease, and hyperlipidemia.
The diagnosis combinations that occur in this temporal pattern are interesting because they do
not fall under the typical signs and symptoms of MI. However, research from the European
Society of Cardiology has shown that myocardial infarctions are common in patients with
cerebrovascular disease and despite conventional diagnostic procedures they often pass
undiscovered [28]. Table 5.9 below shows that the percentage of members with cerebrovascular
disease in Cluster 5 is significantly larger than the percentage of members with cerebrovascular
disease in the overall cost bucket 3 population.
*
10%
21%
Diagnosis
9 months
Ear, Nose, Throat & Upper Respiratory Disorders
Hypertension
Cerebrovascular Disease
28% 13% Coronary Artery Disease
13% 18% Ear, Nose, Throat & Upper Respiratory Disorders
6% 4% Pneumonia
29% 16% 6 months Diabetes
27% 34% Hypertension
6% Cerebrovascular Disease
10% 4% Anemias
16% 14% Hyperlipidemia
32% 20% Coronary Artery Disease
12% 16% Ear, Nose, Throat & Upper Respiratory Disorders
28% 11% 3 months Diabetes
28% 30% Hypertension
7% 9% Cerebrovascular Disease
14% 13% Hyperlipidemia
5.9: Diagnoses that distinguish Cluster 5 from the cost bucket 3 population average. The
first two columns show the percentage of members who have the listed diagnosis.
5.8 Patterns associated with Diabetes, Hypertension, and Hyperlipidemia
In addition to the clusters described above, the algorithms found other unique clusters with
interesting diagnostic temporal patterns that lead to MI. Moreover, the diagnostic characteristics
of the members within these clusters are well-recognized in the medical community and society.
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For example, Cluster 10 from the spectral model in cost bucket 3 exhibits a temporal diagnostic
pattern of diabetes (Figure 5.10). It is commonly known that both types 1 and 2 diabetes are
associated with accelerated atherosclerosis, one of the main causes of myocardial infarction [3].
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Figure 5.10: Cluster 10 in the spectral clustering model from bucket 3. The red line depicts the
average number of doctor visits for each diagnosis for members in Cluster 10. The blue columns
are the average number of doctor visits for each diagnosis for the entire population in bucket 3.
In Section 1, we reviewed the diagnoses that are well-know to lead to MI by the medical
community and society. These diagnoses - diabetes, hypertension and hyperlipidemia -
characterize many of the patterns that consistently occur throughout all of the cost buckets and
clustering models. In the spectral clustering model from cost bucket 1, Cluster 1 consists of
members with hypertension. Members from Cluster 3 experience hypertension only six months
before the MI and members from Cluster 4 experience hypertension only three months before the
MI. Cluster 8 contains members with hyperlipidemia and in Cluster 9 members have diabetes.
While using the k-means clustering algorithm in cost bucket 1, we also encountered patterns of
well-known diagnoses. For example, one cluster consisted of members with hyperlipidemia,
another consisted of members who have diabetes, and another contained members with
hypertension. In cost bucket 2 we find the same kinds of patterns. Cluster 5 from the spectral
model and Cluster 2 from the k-means model both contain members with diabetes. Cluster 10
from the spectral model and Cluster 10 from the k-means model both consist of members with
hypertension. In Cluster 9 from the k-means model, members have complicated hypertension.
In cost bucket 3, the diagnostic patterns are slightly more complicated because patients have
worse health conditions, but we still find patterns that consist of well-known diagnoses leading
to MI: the diabetes members in Cluster 10 (Figure 5.10 above), members in Cluster 7 who have
hyperlipidemia and chest pain, and members in Cluster 9 who have only chest pain.
In addition to the validity of our clusters, we find that our results are also stable. The stability of
the temporal patterns we found is evident because many of the diagnostic patterns occur in
clusters from both algorithms. This helps to show that our results are not a coincidental product
of a single clustering algorithm.
5.9 Patterns associated with No MI
To enhance the analysis from above we present a few insights into the patterns associated with
clusters consisting of a large number of "no MI" members. These findings can be helpful in not
only showing what patterns of diagnoses are not associated with heart attacks, but also how the
timing of certain diagnostic events is critical. In Figure 5.11 below, we see that members in
spectral Cluster 3 from Bucket 2 visit the doctor an average of 15 times for chest pain nine
months before the MI target period.
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Figure 5.11: Cluster 3 in the spectral clustering model from bucket 2.
Referring back to Section 5.3, we found that members in these patterns visited the doctor an
average of 18 to 25 times for chest pain three months before experiencing a heart attack. This
suggests that the timing and number of visits to the doctor for chest pain is critical. If nine
months have passed since the individual visited the doctor for significant occurrence of chest
pain, the chance of a heart attack occurring is less. Additionally, if the number of visits to the
doctor for chest pain is 17 or fewer, the chance of a heart attack occurring is also less.
In Figure 5.12 below, we see that members in spectral Cluster 9 from cost bucket 2 visit the
doctor an average of 16 times for CAD nine months before the MI target period.
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Figure 5.12: Cluster 9 in the spectral clustering model from bucket 2.
Referring back to Section 5.4, we found that members in Cluster 6 visited the doctor an average
of 22 times for CAD three months before having a heart attack. Again, this suggests that the
timing and magnitude of the CAD diagnosis is significant. If nine months have passed since the
individual visited the doctor for significant occurrence of CAD, the chance of a heart attack
occurring is less. Additionally, if the number of visits to the doctor for CAD is 21 or fewer, the
chance of a heart attack occurring is also less.
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5.10 Summary of Results
In summary, we observe that both clustering algorithms improve myocardial infarction
predictions over the baseline method. We also found that the improvement is more significant
for more costly members in higher cost buckets and more significant with the spectral clustering
algorithm. Finally, we found that the diagnostic characteristics of members in the resulting
clusters formed different interesting temporal patterns that can lead to a heart attack. Many of
the trajectories we found have been shown in independent medical studies to be associated with
or lead to MI. However, this systematic methodology we use is a way to collectively find these
patterns and to validate the findings of previous isolated studies.
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Chapter 6
Conclusions and Future Research
Using clustering methods in conjunction with classification algorithms yields improved
predictions of myocardial infarction over using classification alone. Due to a greater density of
clinical data for members with worse health conditions, we predict myocardial infarction more
accurately for members with high medical costs. In addition to improved prediction accuracy,
we found that the clustering methods also effectively split the members into groups with
different temporal diagnostic patterns leading up to myocardial infarction. The patterns found
can be a useful profile reference for identifying patients at high-risk for myocardial infarction in
the future. Although many of the patterns we found have been shown in independent studies to
lead to MI, our systematic method is a way to collectively find these patterns. This method can
be translated into finding interesting patterns in other diseases and adverse events in the future.
In future research, procedural and prescription drug information could also be included to
enhance the data set used in the clustering and classification process.
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Appendix A
ICD-9-CM diagnosis codes summary
A/B: 001-139 'Infectious disease/Infection: Bacterial disease, Virusdisease, Parasitic disease, Mycosis, Zoonosis
eCancer (CO0-D48, 140-239)
'Tumor
eLymphoid immune (D80-D89, 279)
*Immunodeficiency, Immunoproliferative disorder,
280-289 Hypersensitivity
*Myeloid hematologic (D50-D77, 280-289)
*Anemia, Coagulopathy
E 2 *Endocrine disease, Nutrition disorder, Inborn error
of metabolism
F: 290-319 Mental disorder
G: 320-359 *Nervous system disease, Neurmuscular disease
H 360-389 Eye disease, Ear disease
390-459 Cardiovascular disease
J: 460-519 'Respiratory disease
K: 520-579 eStomatognathic disease, Digestive disease
L: 680-709 eSkin disease, skin appendages
M 710-739 eMusculoskelatal disorders, Osteochondropathy
N: 580-629 'Urologic disease, Male genital disease, Breast disease,Female genital disease
'Complications of pregnancy, Obstetric labor
complication, Puerperal disorder
P 760-779 eFetal disease
Q 740-759 Congenital disorder
R 780-799 Syndromes, Medical signs
S/T: 800-999 Bone fracture, Joint dislocation, Sprain, Strain,Subluxation, Head injury, Chest trauma, Poisoning
.......... ... - .- - ...............................  ... ...........   . . .
ICD-9-CM procedure codes summary
*Surgery, Nervous system: Neurosurgical and other
procedures
06-07 eEndocrine system intervention
-816eSurgery, Eye surgery and other procedures
1 * *Operations/surgeries and other procedures on theear
2-9*Operations/surgeries and other procedures on the
mouth, and pharynx
3 A *Respiratory system surgeries and other procedures
3Health science - Medicine, Surgery, Cardiac
procedures
*Health science - Medicine, Surgery, Vascular surgery
and other vascular procedures
*Operations/surgeries and other procedures of the
hemic and lymphatic system
4 5 eDigestive system surgical and other procedures
-55*Urologic surgical and other procedures
6 e 'Genital surgical and other procedures
'Obstetrical surgery and other procedures
'Orthopedic surgery, operations/sugeries and other
procedures on bones and joints
82 8*Orthopedic surgery, operations/surgeries and other
procedures on muscle/soft tissue
8Operations/surgeries and other procedures of the
breast
86 *Operations/surgeries and other procedures of the
skin and subcutaneous tissue
.......... ------
Appendix B
An example of 43 ICD-9-CM diagnosis codes reduced into one Myocardial Infarction diagnosis
group
410 Acute Myocardial Infarction DD0028 Myocardial Infarction
Acute Myocardial Infarction Anterolateral
4100 Wall DD0028 Myocardial Infarction
Acute Myocardial Infarction Anterolateral
41000 Wall DD0028 Myocardial Infarction
Acute Myocardial Infarction Anterolateral
41001 Wall DD0028 Myocardial Infarction
Acute Myocardial Infarction Anterolateral
41002 Wall DD0028 Myocardial Infarction
4101 Acute Myocardial Infarction Anterior Wall DD0028 Myocardial Infarction
41010 Acute Myocardial Infarction Anterior Wall DD0028 Myocardial Infarction
41011 Acute Myocardial Infarction Anterior Wall DD0028 Myocardial Infarction
41012 Acute Myocardial Infarction Anterior Wall DD0028 Myocardial Infarction
Acute Myocardial Infarction Inferolateral
4102 Wall DD0028 Myocardial Infarction
Acute Myocardial Infarction Inferolateral
41020 Wall DD0028 Myocardial Infarction
Acute Myocardial Infarction Inferolateral
41021 Wall DD0028 Myocardial Infarction
Acute Myocardial Infarction Inferolateral
41022 Wall DD0028 Myocardial Infarction
4104 Acute Myocardial Infarction Inferior Wall DD0028 Myocardial Infarction
41040 Acute Myocardial Infarction Inferior Wall DD0028 Myocardial Infarction
41041 Acute Myocardial Infarction Inferior Wall DD0028 Myocardial Infarction
41042 Acute Myocardial Infarction Inferior Wall DD0028 Myocardial Infarction
4105 Acute Myocardial Infarction Ateral Wall DD0028 Myocardial Infarction
41050 Acute Myocardial Infarction Ateral Wall DD0028 Myocardial Infarction
41051 Acute myocardial infarction lateral wall DD0028 Myocardial Infarction
41052 Acute Myocardial Infarction Ateral Wall DD0028 Myocardial Infarction
4106 True Posterior Wall Infarction DD0028 Myocardial Infarction
41060 True Posterior Wall Infarction DD0028 Myocardial Infarction
41061 True Posterior Wall Infarction DD0028 Myocardial Infarction
Acute Myocardial Infarction Inferoposterior
4103 Wall DD0028 Myocardial Infarction
Acute Myocardial Infarction Inferoposterior
41030 Wall DD0028 Myocardial Infarction
Acute Myocardial Infarction Inferoposterior
41031 Wall DD0028 Myocardial Infarction
Acute Myocardial Infarction Inferoposterior
41032 Wall DD0028 Myocardial Infarction
41062 True Posterior Wall Infarction DD0028 Myocardial Infarction
4107 Subendocardial Infarction DD0028 Myocardial Infarction
41070 Subendocardial Infarction DD0028 Myocardial Infarction
41071 Subendocardial Infarction DD0028 Myocardial Infarction
41072 Subendocardial Infarction DD0028 Myocardial Infarction
4108 Acute Myocardial Infarction Sites DD0028 Myocardial Infarction
41080 Acute Myocardial Infarction DD0028 Myocardial Infarction
41081 Acute Myocardial Infarction Sites DD0028 Myocardial Infarction
41082 Acute Myocardial Infarction Sites DD0028 Myocardial Infarction
4109 Acute Myocardial Infarction Sites DD0028 Myocardial Infarction
41090 Acute Myocardial Infarction Sites DD0028 Myocardial Infarction
41091 Acute myocardial infarction DD0028 Myocardial Infarction
41092 Acute Myocardial Infarction DD0028 Myocardial Infarction
4110 Postmyocardial Infarction Syndrome DD0028 Myocardial Infarction
4297 Certain Sequelae of Myocardial Infarction, DD0028 Myocardial Infarction
Appendix C
List of diagnosis codes used
1 DD0002 CAD
2 DD0004 ENT & Upper Respiratory Disorders
3 DD0012 Chest Pain
4 DD0028 Myocardial Infarction
5 DD0032 Pneumonia
6 DD0046 Diabetes
7 DD0052 CHF
8 DD0058 Dysrhythmias
9 DD0062 COPD
10 DD0064 Hypertension
11 DD0068 Lung Cancer
12 DD0074 Cancer Therapies
13 DD0082 Lower Resp. Disorders
14 DD0084 Resp. Failure
15 DD0086 Cerebrovascular Disease
16 DD0094 Heart Valve Disorders
17 DD0102 Screening
18 DD0110 Anemia
19 DD0120 Shortness Of Breath
20 DD0128 Peripheral Vascular Diseases
21 DD0140 Atrial Fibrillation
22 DD0142 Hyperlipidemia
23 DD0146 Metabolic Disorders
24 DD0148 Asthma
25 DD0164 Leukemia
26 DD0172 Obesity
27 DD0178 Aortic Diseases
28 DD0204 Diseases of Pulmonary Circulation
29 DD0208 sudden death or other morbidity
30 DD0246 Myocardial Diseases
31 DD0248 Cough
32 DD0254 History of Condition
33 DD0274 organ transplants
34 DD0276 Complicated Hypertension
35 DD0332 Pericardial Diseases
36 DD0336 Vasculitis
37 DD0344 Severe Cardiac Conduction Disorder
DD0346
DD0350
DD0352
DD0360
DD0388
DD0404
DD0406
DD0412
DD0428
OtherDiag
Cardiac Conduction Disorder
Atherosclerosis
Hypotension
Endocardial Diseases
Misc Heart Diseases
Sarcoidosis
Family History of Condition
Tuberculosis
Hyperalimentation
Other Diagnosis
Appendix D
21 periods, each of 90 days in length over the observation period
1 1/27/2000 - 11/30/2002
2 12/1/2002 - 2/28/2003
3 3/1/2003 - 5/29/2003
4 5/30/2003 - 8/27/2003
5 8/28/2003 - 11/25/2003
6 11/26/2003 - 2/23/2004
7 2/24/2004 - 5/23/2004
8 5/24/2004 - 8/21/2004
9 8/21/2004 - 11/19/2004
10 11/20/2004 - 2/17/2005
11 2/18/2005 - 5/18/2005
12 5/19/2005 - 8/16/2005
13 8/17/2005 - 11/14/2005
14 11/15/2005 - 2/12/2006
15 2/13/2006 - 5/13/2006
16 5/14/2006 - 8/11/2006
17 8/12/2006 - 11/9/2006
18 11/10/2006 - 2/7/2007
19 2/8/2007 - 5/8/2007
20 5/9/2007 - 8/6/2007
21 8/7/2007 - 11/30/2007
